Defiance Autism Impact ETF Holdings

ASDNASDAQ
$27.03
-0.0069-0.03%
At close: Sep 23, 5:00 PM EST
$27.10
0.0650.24%
Pre-Market: 4:07 AM EST

As of Sep 15, 2026

Number of Stock Holdings

38

Number of Bond Holdings

-

Total Holdings

40

Number of ETFs

-

Defiance Autism Impact ETF (NASDAQ:ASD), Top Holdings

Defiance Autism Impact ETF (NASDAQ: ASD)

TickerNameShare %
CADefinium Therapeutics, Inc. Common Shares4.04%
LFSTLifeStance Health Group Inc.3.76%
ACADAcadia Pharmaceuticals Inc3.11%
NZNeuren Pharmaceuticals Ltd3.81%
RGENRepligen Corp3.05%
ZALife Healthcare Group Holdings Ltd2.81%
RVTYRevvity Inc3.07%
BMRNBiomarin Pharmaceutical Inc2.89%
TKSumitomo Pharma Co., Ltd.2.82%

FAQ

Q

How has ASD ETF performed?

A

The ASD ETF is currently trading at $27.1, which represents a 0.27% change. Over the past 52 weeks, the ETF has traded as high as $28.52 and as low as $24.59.

Q

What is the expense ratio for ASD?

A

The expense ratio of ASD is 0.79%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for ASD?

A

The total Assets Under Management (AUM) for ASD is 1.35M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for ASD?

A

ASD follows a Large Cap Value investment style.

Q

What are the top holdings for ASD?

A

The top holdings of ASD include: CA (4.04%), LFST (3.76%), ACAD (3.11%), NZ (3.81%), RGEN (3.05%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for ASD?

A

Average daily volume data for ASD is currently not available.